Haematopoietic cell transplantation as immunotherapy

被引:340
作者
Appelbaum, FR [1 ]
机构
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA
关键词
D O I
10.1038/35077251
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The graft-versus-tumour effect seen after allogeneic (genetically different) haematopoietic cell transplantation for human malignancies represents the clearest example of the power of the human immune system to eradicate cancer. Recent advances in our understanding of the immunobiology of stem-cell engraftment, tolerance and tumour eradication are allowing clinicians to better harness this powerful effect.
引用
收藏
页码:385 / 389
页数:5
相关论文
共 60 条
[21]   Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry (Reprinted from Science, vol 255, March 6, 1992) [J].
Hunt, Donald F. ;
Henderson, Robert A. ;
Shabanowitz, Jeffrey ;
Sakaguchi, Kazuyasu ;
Michel, Hanspeter ;
Sevilir, Noelle ;
Cox, Andrea L. ;
Appella, Ettore ;
Engelhard, Victor H. .
JOURNAL OF IMMUNOLOGY, 2007, 179 (05) :2669-2671
[22]   Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia [J].
Inoue, K ;
Ogawa, H ;
Sonoda, Y ;
Kimura, T ;
Sakabe, H ;
Oka, Y ;
Miyake, S ;
Tamaki, H ;
Oji, Y ;
Yamagami, T ;
Tatekawa, T ;
Soma, T ;
Kishimoto, T ;
Sugiyama, H .
BLOOD, 1997, 89 (04) :1405-1412
[23]  
KERNAN NA, 1994, BONE MARROW TRANSPL, P124
[24]   Transplant-lite:: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor cell transplantation as treatment for lymphoid malignancies [J].
Khouri, IF ;
Keating, M ;
Körbling, M ;
Przepiorka, D ;
Anderlini, P ;
O'Brien, S ;
Giralt, S ;
Ippoliti, C ;
von Wolff, B ;
Gajewski, J ;
Donato, M ;
Claxton, D ;
Ueno, N ;
Andersson, B ;
Gee, A ;
Champlin, R .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2817-2824
[25]   Advances in immunology - The HLA system - First of two parts [J].
Klein, J ;
Sato, A .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (10) :702-709
[26]   GRAFT-VERSUS-LEUKEMIA EFFECT OF DONOR LYMPHOCYTE TRANSFUSIONS IN MARROW GRAFTED PATIENTS [J].
KOLB, HJ ;
SCHATTENBERG, A ;
GOLDMAN, JM ;
HERTENSTEIN, B ;
JACOBSEN, N ;
ARCESE, W ;
LJUNGMAN, P ;
FERRANT, A ;
VERDONCK, L ;
NIEDERWIESER, D ;
VANRHEE, F ;
MITTERMUELLER, J ;
DEWITTE, T ;
HOLLER, E ;
ANSARI, H .
BLOOD, 1995, 86 (05) :2041-2050
[27]   Cytokine cascades in acute graft-versus-host disease [J].
Krenger, W ;
Hill, GR ;
Ferrara, JLM .
TRANSPLANTATION, 1997, 64 (04) :553-558
[28]   A CELL INITIATING HUMAN ACUTE MYELOID-LEUKEMIA AFTER TRANSPLANTATION INTO SCID MICE [J].
LAPIDOT, T ;
SIRARD, C ;
VORMOOR, J ;
MURDOCH, B ;
HOANG, T ;
CACERESCORTES, J ;
MINDEN, M ;
PATERSON, B ;
CALIGIURI, MA ;
DICK, JE .
NATURE, 1994, 367 (6464) :645-648
[29]   CD28/B7 system of T cell costimulation [J].
Lenschow, DJ ;
Walunas, TL ;
Bluestone, JA .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :233-258
[30]   LONG-TERM SURVIVAL OF XENOGENEIC PANCREATIC-ISLET GRAFTS INDUCED BY CTLA4IG [J].
LENSCHOW, DJ ;
ZENG, YJ ;
THISTLETHWAITE, JR ;
MONTAG, A ;
BRADY, W ;
GIBSON, MG ;
LINSLEY, PS ;
BLUESTONE, JA .
SCIENCE, 1992, 257 (5071) :789-792